Abstract
The SAR development is described for a series of N-acyl pyrrolidine inhibitors of the Hepatitis C virus RNA-dependent RNA polymerase, NS5B, from tractable Delta21 enzyme inhibitors to an example with antiviral activity in a cellular assay (HCV replicon).
MeSH terms
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Chemistry, Pharmaceutical / methods*
-
Drug Design
-
Enzyme Inhibitors / pharmacology
-
Hepacivirus / chemistry*
-
Hepacivirus / genetics*
-
Inhibitory Concentration 50
-
Models, Chemical
-
Molecular Conformation
-
Pyrrolidines / antagonists & inhibitors*
-
RNA, Viral / chemistry
-
RNA-Dependent RNA Polymerase / antagonists & inhibitors*
-
Replicon / genetics*
-
Viral Nonstructural Proteins / chemistry
-
Viral Nonstructural Proteins / pharmacology*
-
Virus Replication / drug effects
Substances
-
Antiviral Agents
-
Enzyme Inhibitors
-
Pyrrolidines
-
RNA, Viral
-
Viral Nonstructural Proteins
-
NS-5 protein, hepatitis C virus
-
RNA-Dependent RNA Polymerase
-
pyrrolidine